{"id":"NCT00411463","sponsor":"University of Pittsburgh","briefTitle":"Psychotherapy for Bipolar II Depression, Pilot Study, Phase II","officialTitle":"Psychotherapy for Bipolar II Depression, Pilot Study, Phase II","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-12","primaryCompletion":"2010-09","completion":"2010-09","firstPosted":"2006-12-14","resultsPosted":"2017-04-19","lastUpdate":"2017-05-30"},"enrollment":25,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar II Disorder"],"interventions":[{"type":"BEHAVIORAL","name":"Interpersonal and Social Rhythm Therapy (IPSRT-BPII)","otherNames":["IPSRT"]},{"type":"DRUG","name":"Seroquel","otherNames":["Quetiapine"]}],"arms":[{"label":"Psychotherapy","type":"EXPERIMENTAL"},{"label":"Medication","type":"EXPERIMENTAL"}],"summary":"Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will be randomly assigned to receive either IPSRT-BPII or the medication Seroquel (quetiapine) to manage their symptoms of bipolar II depression. Subjects will receive the assigned therapy for up to 20 weeks.","primaryOutcome":{"measure":"Number of Participants With Greater Than or Equal to 50% Reduction in Depression Scores, With a Mania Score Less Than or Equal to 10","timeFrame":"Week 12","effectByArm":[{"arm":"Psychotherapy","deltaMin":4,"sd":null},{"arm":"Medication","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22420597"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":[]}}